Marshall Wace
CLMT icon

Marshall Wace’s Calumet Specialty Products CLMT Stock Holding History

Marshall Wace’s Portfolio CLMT Stock Details CLMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$29.6M Buy
824,028
+56,198
+7% +$1.45M 0.03% 555
2025
Q4 		$15.3M Sell
767,830
-123,560
-14% -$2.38M 0.01% 730
2025
Q3 		$16.3M Buy
891,390
+234,766
+36% +$3.86M 0.02% 745
2025
Q2 		$10.3M Sell
656,624
-297,905
-31% -$3.79M 0.01% 827
2025
Q1 		$12.1M Buy
954,529
+634,505
+198% +$9.97M 0.02% 701
2024
Q4 		$7.05M Buy
+320,024
New +$6.73M 0.01% 924
2019
Q4 		– Sell
-7,455
Closed -$27K – 1734
2019
Q3 		$27K Buy
+7,455
New +$31.9K ﹤0.01% 1583
2016
Q1 		– Sell
-209,614
Closed -$4.17M – 1044
2015
Q4 		$4.17M Buy
+209,614
New +$5.18M 0.04% 416
2015
Q3 		– Sell
-119,691
Closed -$3.05M – 932
2015
Q2 		$3.05M Buy
+119,691
New +$3.17M 0.04% 387
2013
Q2 		$6.5M Buy
+178,772
New +$6.43M 0.39% 50

Other funds holding CLMT

TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WDOM
Wasserstein Debt Opportunities Management New York $189M AUM 169.75% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AAA
Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Marshall Wace's CLMT Position: Q1 2026 in Review

Marshall Wace increased its Calumet Specialty Products (CLMT) stake by 7.3% in Q1 2026, buying an estimated $1.45M and bringing the position to 824,028 shares worth $29.6M. The position accounts for 0.03% of the portfolio, ranked #555.

Marshall Wace first reported a position in CLMT in Q2 2013 and has held it in 10 quarters since. 180 funds tracked by Wall St. Rank hold CLMT as of Q1 2026.

  • Marshall Wace held 824,028 shares of Calumet Specialty Products worth $29.6M as of Q1 2026.
  • Marshall Wace bought 56,198 Calumet Specialty Products shares in Q1 2026, an estimated $1.45M.
  • Calumet Specialty Products made up 0.03% of Marshall Wace's portfolio in Q1 2026, its #555 holding.
  • Marshall Wace first reported a position in Calumet Specialty Products in Q2 2013 and has held it in 10 quarters since.
  • 180 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.